Alendronate sodium hydrate
CAS No. 121268-17-5
Alendronate sodium hydrate ( Alendronate;MK 217;G-704650 Adronat )
Catalog No. M10794 CAS No. 121268-17-5
Alendronate sodium hydrate (Alendronate;MK 217;G-704650 Adronat) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
50MG | 36 | In Stock |
|
100MG | 43 | In Stock |
|
200MG | 49 | In Stock |
|
500MG | 77 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAlendronate sodium hydrate
-
NoteResearch use only, not for human use.
-
Brief DescriptionAlendronate sodium hydrate (Alendronate;MK 217;G-704650 Adronat) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption.
-
DescriptionAlendronate sodium hydrate (Alendronate;MK 217;G-704650 Adronat) is a bisphosphonate that acts as a specific inhibitor of osteoclastmediated bone resorption, inhibits osteoclast protein-tyrosine phosphatase (PTPepsilon) with IC50 of 2 uM; also inhibits the activities of other bacterially expressed PTPs such as PTPsigma and CD45, suppresses in vitro formation of multinucleated osteoclasts from osteoclast precursors and in vitro bone resorption by isolated rat osteoclasts with IC50 of 10 uM; also is also inhibits farnesyl disphosphate synthase with IC50 of 1.7 uM.Osteoporosis Approved
-
SynonymsAlendronate;MK 217;G-704650 Adronat
-
PathwayOthers
-
TargetOther Targets
-
RecptorFarnesyldiphosphatesynthase
-
Research AreaMetabolic Disease
-
IndicationOsteoporosis
Chemical Information
-
CAS Number121268-17-5
-
Formula Weight325.12
-
Molecular FormulaC4H18NNaO10P2
-
Purity>98% (HPLC)
-
SolubilityH2O: ≥ 28.57 mg/mL; DMSO: < 3.2 mg/mL
-
SMILESOC(P([O-])(O)=O)(P(O)(O)=O)CCCN.[H]O[H].[H]O[H].[H]O[H].[Na+]
-
Chemical NamePhosphonic acid, P,P'-(4-amino-1-hydroxybutylidene)bis-, sodium salt, hydrate (1:1:3)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bergstrom JD, et al. Arch Biochem Biophys. 2000 Jan 1;373(1):231-41.
2. Opas EE, et al.Biochem Pharmacol. 1997 Sep 15;54(6):721-7.
3. David P, et al. J Bone Miner Res. 1996 Oct;11(10):1498-507.
4. Schmidt A, et al. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3068-73.
2. Opas EE, et al.Biochem Pharmacol. 1997 Sep 15;54(6):721-7.
3. David P, et al. J Bone Miner Res. 1996 Oct;11(10):1498-507.
4. Schmidt A, et al. Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):3068-73.
molnova catalog
related products
-
VU 0357121
VU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.
-
ICCB280
ICCB280 was capable of inducing differentiation and apoptosis of ATRA-resistant patient blasts strongly signify that the activity of this compound can overcome resistance to other current therapies for AML with an unfavorable prognosis.
-
Sodium glucoheptonat...
Sodium Glucoheptonate is available as a Tc-99m radiolabeling kit. Tc-99m glucoheptonate is a kidney and brain imaging agent for brain tumor detection.